• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Infectious Disease

[Physician Comment] Recurrent early Lyme disease is caused by reinfection, not relapse

bys25qthea
November 21, 2012
in Infectious Disease
Reading Time: 4 mins read
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD 

Study Author Dr. Robert Nadelman, MD talks to 2 Minute Medicine Division of Infectious Diseases, New York Medical College:

“Our findings should reassure clinicians and patients that standard courses of appropriate antibiotics regularly cure early Lyme disease associated with an erythema migrans skin lesion, and that recurrences of erythema migrans are reinfections (transmitted by a new tick bite), rather than relapses. Our results are also consistent with existing clinical and epidemiologic information. For instance, recurrent erythema migrans skin lesions develop after one year or more at a different body site than the original lesion, and occur during the summer at the height of activity of nymphal Ixodes scapularis (deer ticks); a preceding new tick bite at the exact site of the recurrent rash was recalled by 27% of our patients. 

Persons living, working, or spending time in recreation in areas endemic for deer ticks remain at risk for tick-borne infections including repeat episodes of Lyme disease. Therefore, efforts should be made to educate the community on how to avoid tick bites, and on the importance of removing ticks as soon as possible before they can transmit infection.”

Key study points:  

  1. Cases of recurrent Lyme infection were caused by different strains of B. burgdorferi versus initial infections.
  2. Recurrent Lyme appears to be caused by reinfection, not relapse.

Primer: Lyme disease is a tick-borne infection caused by the spirochete Borrelia burgdorferi.  Incidence of Lyme infection has been steadily increasing for several decades, particularly in the Northeastern United States.

RELATED REPORTS

In topline phase 3 results, nomelcitinib improved PASI 90 and PGA 0/1 responses versus placebo in plaque psoriasis

Intraosseous cefuroxime (Ceftin) may improve tissue delivery compared to intravenous administration during total knee arthroplasty

Lyme infection causes a multi-stage disease beginning with a febrile illness and characteristic rash called erythema migrans (EM).  If left untreated, patients can develop disseminated disease that may involve multiple EM lesions, neurologic and/or cardiac involvement.

Lyme can generally be treated successfully with antibiotics, but a small number of patients experience recurrent or persistent symptoms after appropriate treatment.  These cases of “recurrent” and “chronic” Lyme disease have been a source of controversy.  Many patients and advocacy groups believe in extending antibiotic courses for years to prevent relapsing and chronic disease, while the Infectious Diseases Society of America does not believe there is evidence to support this practice.

Case reports and epidemiologic data suggested that recurrent Lyme results from reinfection, though this assumption had not been definitively supported. To determine whether recurrent Lyme is indeed caused by reinfection, the authors of this study compared the Lyme genotypes of patients with recurrent Lyme disease to the genotypes of their consecutive preceding infections. Of note, this study specifically addresses the issue of recurrent early Lyme, not disseminated or late disease. 

Background reading:

1. Clinical manifestations of Lyme disease in adults.

2. Reinfection in patients with Lyme disease.

3. Reinfection and relapse in early Lyme disease.

This [molecular typing] study examined data and specimens collected from prior prospective studies of Lyme disease.  Twenty-four episodes of recurrent EM with positive cultures (referred to as paired consecutive episodes) were identified in 17 patients; however only 22 episodes had adequate samples for genotyping.  B. burgdorferi DNA was extracted from positive skin or blood cultures for each episode of EM and used to determine the pathogens’ genotypes.  In all cases, no two consecutive episodes of Lyme infection produced the same strain of B. burgdorferi, suggesting these recurrent episodes resulted from reinfection rather than relapse of the prior infection.

In sum: This is the first study to evaluate a cohort of patients for evidence of reinfection in recurrent Lyme disease.  By comparing genotypes of the outer surface protein C (ospC) of Lyme isolates obtained in initial and recurrent episodes of EM, this study showed in all cases for which sufficient data was obtained that recurrent Lyme was indeed caused by reinfection.  These results could also suggest that there may be type-specific immunity to Lyme genotypes, though the study was not statistically powered to clearly address this possibility.  Additionally, 2 of the 24 culture-positive paired episodes of EM were unavailable for genotyping.  Therefore relapsing infection cannot be ruled out in these cases.  Though logistically difficult, a prospective study may be helpful going forward to further support the notion that recurrent early Lyme is indeed caused by reinfection.  

Click to read the study in [NEJM]  

Click to read an accompanying editorial in [NEJM]  

By [AS] and [MP]  

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Previous Post

[Physician Comment] Bipolar Disorder is associated with adverse pregnancy outcomes regardless of pharmacologic treatment

Next Post

Combination therapy of a monoclonal antibody and atorvastatin may help patients reach target LDL levels

RelatedReports

Psoriasis collage: an elbow with raised scaly patches, a jar of thick cream, oat stalks and a light therapy panel
2MM Trial Briefs

In topline phase 3 results, nomelcitinib improved PASI 90 and PGA 0/1 responses versus placebo in plaque psoriasis

November 2, 2026
Osteoarthritis collage: an engraved knee joint with worn cartilage, walking shoes and a hot-water bottle
Infectious Disease

Intraosseous cefuroxime (Ceftin) may improve tissue delivery compared to intravenous administration during total knee arthroplasty

November 2, 2026
Migraine collage of a young woman resting with eyes closed beside a teal zigzag ribbon, a curtained window and water
Weekly Rewinds

2 Minute Medicine Rewind November 2, 2026

November 2, 2026
Mitral valve prolapse collage of an engraved heart with a parachute-like valve, a stethoscope and a calm woman
Cardiology

Early mitral valve surgery may improve long-term survival in asymptomatic severe mitral regurgitation

October 31, 2026
Next Post

Combination therapy of a monoclonal antibody and atorvastatin may help patients reach target LDL levels

Cardiopulmonary exercise testing is safe for high-risk cardiovascular patients

Low molecular weight heparin most effective at reducing rate of venous thromboembolism in patients undergoing bariatric surgery

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • In topline phase 3 results, nomelcitinib improved PASI 90 and PGA 0/1 responses versus placebo in plaque psoriasis
  • Intraosseous cefuroxime (Ceftin) may improve tissue delivery compared to intravenous administration during total knee arthroplasty
  • 2 Minute Medicine Rewind November 2, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.